Skip to content

A Clinical Trial of Nagaradi Syrup in the management of Dysmenorrhea

Evaluation of the Efficacy of Nagaradi kwath in the management of Vataja Artava Dusti

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045246
Enrollment
30
Registered
2022-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

None listed

Sponsors

NEKIB HUSSAIN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients with the chief complaint of painful menstruation, for at least 3 cycles (patient with regular menstrual cycle

Exclusion criteria

Exclusion criteria: 1. Patients with any pelvic pathology such as Fibroid, Adenomyosis, Endometriosis ,PID ,Malignancy of pelvic organs etc. 2. Patients suffering from acute infections ,Menorrhagia . 3. Patients with Systemic diseases like Diabetes mellitus ,Chronic Kidney Disease,HIV,Tuberculosis etc

Design outcomes

Primary

MeasureTime frame
Decrease in symptoms of Vataja Artava Dusti (Dysmenorrhea) 1.Pain during menstruation Timepoint: 90 days

Secondary

MeasureTime frame
Decrease in symptoms of Vataja Artava Dusti like 1.Pain during menstruation 2. Reddish Or Blackish Menstrual Blood 3.Scanty bleeding Timepoint: 60 Days

Countries

India

Contacts

Public ContactDr Kaushalya Khakhlary

Govt. Ayurvedic College and Hospital,jalukbari,Guwahati,Assam

drkaushalya01@gmail.com8638787369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026